Co-Diagnostics Inc (CODX)

[turning stone]

This puppy needs to absorb the 3.3 offering and slowly and orderly move back up to prior the offering price. The FDA approval is the big deal here. Time is on our side not the FDA's. Co-Diagnostics needs to be more transparent with the shareholders as to number of orders and revenue generated to help the share price. This is a young company by all respects and I am sure this will be a learning experience for them as well. The longs here must keep in mind that whatever the SHORTS write here really falls on deaf ears as the real investors don't know about INVESTORShub nor would they care if they did. So shorts spew your trash and get it out of your system.The real world doesn't hear you or read you.